Bradyarrhythmias in patients with obstructive sleep apnea

Aim. To compare patients with bradyarrhythmias and obstructive sleep apnea (OSA) and patients without OSA; to study the predictive capabilities of questionnaires in OSA screening.

Material and methods. The study included 134 patients with bradyarrhythmias hospitalized for pacemaker implantation or pacemaker replacement. The median age was 67.5 years (interquartile range 59 to 72 years). Sleep apnea screening was performed using the Berlin questionnaire, the STOP-BANG sleep apnea risk scale, and the Epworth sleepiness scale. All patients underwent blood tests and instrumental examinations (respiratory monitoring and echocardiography).

Results. Patients with OSA were older (68 years versus 64 years; p = 0.032), had a larger waist circumference (116 cm versus 108 cm; p = 0.044), and body mass index (33.7 kg/m² versus 31.03 kg/m²; p = 0.016) compared to patients without OSA. The Berlin questionnaire (area under the curve (AUC) 0.79; sensitivity 92 %, specificity 38 %; p <0.0001) and the STOP-BANG risk scale (AUC 0.75; sensitivity 82 %, specificity 23 %; p <0.0001) had a high predictive power to identify sleep apnea while the Epworth sleepiness scale had a low predictive power (AUC 0.463; sensitivity 12 %, specificity 85 %). According to laboratory and instrumental data, patients with sleep apnea had significantly higher C-reactive protein levels (7.17 mg/L versus 1.73 mg/L; p = 0.012) and more frequently had interventricular septal hypertrophy (12 mm versus 10 mm; p = 0.02). Third-degree atrioventricular block was significantly more common in patients with sleep apnea (17.91 % versus 5.97 %; odds ratio 0.363; 95 % confidence interval 0.131–1.001; p = 0.045). In patients with sleep apnea, cardiac pacing for more than 5 years was more common (11.94 % versus 4.48 %; odds ratio 0.35; 95 % confidence interval 0.116–1.054; p = 0.049).

Conclusion. High frequency of OSA was observed in patients with bradysystolic heart rate. The Berlin questionnaire and the STOP-BANG sleep apnea risk scale can be used to screen for OSA in patients with bradyarrhythmias. Elevated C-reactive protein levels and interventricular septal hypertrophy accentuate the importance of early diagnosis and treatment of OSA for improved prognosis.

1. Cao J., Herman A.B., West G.B. et al. Unraveling why we sleep: quantitative analysis reveals abrupt transition from neural reorganization to repair in early development. Sci Adv 2020 6(38):eaba0398. DOI: 10.1126/sciadv.aba0398

2. Yeghiazarians Y., Jneid H., Tietjens J.R. et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2021;144(3):e56–67. DOI: 10.1161/CIR.0000000000000988

3. Jaspan V.N., Greenberg G.S., Parihar S. et al. The role of sleep in cardiovascular disease. Curr Atheroscler Rep 2024;26(7):249–62. DOI: 10.1007/s11883-024-01207-5

4. Laczay B., Faulx M.D. Obstructive sleep apnea and cardiac arrhythmias: a contemporary review. J Clin Med 2021;10(17):3785. DOI: 10.3390/jcm10173785

5. Martí-Almor J., Jiménez-López J., Casteigt B. et al. Obstructive sleep apnea syndrome as a trigger of cardiac arrhythmias. Curr Cardiol Rep 2021;23(3):20. DOI: 10.1007/s11886-021-01445-y

6. Teo Y.H., Han R., Leong S. et al. Prevalence, types and treatment of bradycardia in obstructive sleep apnea – a systematic review and meta-analysis. Sleep Med 2022;89:104–13. DOI: 10.1016/j.sleep.2021.12.003

7. Roche F., Xuong A.N., Court-Fortune I. et al. Relationship among the severity of sleep apnea syndrome, cardiac arrhythmias, and autonomic imbalance. Pacing Clin Electrophysiol 2003;26(3):669–77. DOI: 10.1046/j.1460-9592.2003.00116.x

8. Garrigue S., Pépin J.L., Defaye P. et al. High prevalence of sleep apnea syndrome in patients with long-term pacing: the European Multicenter Polysomnographic Study. Circulation 2007; 115(13):1703–9. DOI: 10.1161/CIRCULATIONAHA.106.659706

9. Szajerska-Kurasiewicz A., Loboda D., Roleder T. et al. Sleepdisordered breathing as a risk factor for unnecessary pacemaker implantation. Kardiol Pol 2022;80(2):191–7. DOI: 10.33963/KP.a2022.0011

10. Senaratna C.V., Perret J.L., Lodge C.J. et al. Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev 2017;34:70–81. DOI: 10.1016/j.smrv.2016.07.002

11. World Population Prospects 2019. United Nations, New York, 2019. Available at: https://population.un.org/wpp/assets/Files/WPP2019_Highlights.pdf

12. Al Nufaiei Z.F., Alluhibi R.H., Alsabiti M.B. et al. Assessing the knowledge and awareness of obstructive sleep apnea among patient families in saudi arabia: a qualitative study. Int J Gen Med 2024;17:4213–25. DOI: 10.2147/IJGM.S472087

13. Kuna S.T., Reboussin D.M., Strotmeyer E.S. et al. Effects of weight loss on obstructive sleep apnea severity. Ten-year results of the sleep AHEAD Study. Am J Respir Crit Care Med 2021;203(2):221–9. DOI: 10.1164/rccm.201912-2511OC

14. Carneiro-Barrera A., Amaro-Gahete F.J., Guillén-Riquelme A. et al. Effect of an interdisciplinary weight loss and lifestyle intervention on obstructive sleep apnea severity: the INTERAPNEA randomized clinical trial. JAMA Netw Open 2022;5(4):e228212. DOI: 10.1001/jamanetworkopen.2022.8212

15. Wu X., Liu Z., Chang S.C. et al. Screening and managing obstructive sleep apnea in nocturnal heart block patients: an observational study. Respir Res 2016;17:16. DOI: 10.1186/s12931-016-0333-8

16. Guo Q., Song W.D., Li W. et al. Weighted Epworth sleepiness scale predicted the apnea-hypopnea index better. Respir Res 2020;21(1):147. DOI: 10.1186/s12931-020-01417-w

17. Imani M.M., Sadeghi M., Farokhzadeh F. et al. Evaluation of blood levels of C-reactive protein marker in obstructive sleep apnea: a systematic review, meta-analysis and meta-regression. Life (Basel) 2021;11(4):362. DOI: 10.3390/life11040362

18. Kim J., Yoon D.W., Myoung S. et al. Coexistence of moderate-to-severe obstructive sleep apnea and inflammation accelerates the risk of progression of arterial stiffness: a prospective 6-year study. Life (Basel) 2022;12(11):1823. DOI: 10.3390/life12111823

19. Taheri S., Austin D., Lin L. et al. Correlates of serum C-reactive protein (CRP) – no association with sleep duration or sleep disordered breathing. Sleep 2007;30(8):991–6. DOI: 10.1093/sleep/30.8.991

20. Medeiros-Oliveira V.C., Viana R.S., Oliveira A.C. et al. Are sleep time and quality associated with inflammation in children and adolescents? A systematic review. Prev Med Rep 2023;35:102327. DOI: 10.1016/j.pmedr.2023.102327

21. Cuspidi C., Tadic M., Sala C. et al. Obstructive sleep apnea syndrome and left ventricular hypertrophy: a meta-analysis of echocardiographic studies. J Hypertens 2020;38(9):1640–9. DOI: 10.1097/HJH.0000000000002435

22. Cuspidi C., Tadic M., Sala C. et al. Targeting concentric left ventricular hypertrophy in obstructive sleep apnea syndrome. A meta-analysis of echocardiographic studies. Am J Hypertens 2020;33(4):310–5. DOI: 10.1093/ajh/hpz198

23. Khamsai S., Sanlung T., Limpawattana P. et al. Risk factors of left ventricular hypertrophy in obstructive sleep apnea. Biomed Rep 2022;18(1):6. DOI: 10.3892/br.2022.1588

24. Fietze I., Röttig J., Quispe-Bravo S. et al. Sleep apnea syndrome in patients with cardiac pacemaker. Respiration 2000;67(3):268–71. DOI: 10.1159/000029509